Accutar Biotech

Accutar Biotech is a privately held company based in New York, NY. Founded in 2015, Accutar Biotech employs 19 individuals. Accutar Biotech specializes in providing software solutions and services for drug discovery. Their offerings include Chemi-Net, a molecular graph convolutional network for accurate drug property prediction, and Orbital, a deep neural network based docking platform. Additionally, they provide virtual screening for lead discovery, intelligent-SAR for lead optimization, and drug property prediction services. Accutar Biotech differentiates itself through its hybrid approach to drug discovery, combining computational drug design with wet lab validation. This methodology aims to significantly reduce the time and cost traditionally associated with drug discovery efforts. For inquiries, visit Accutar Biotech's website at accutarbio.com.